Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S
Go back to Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 5.16 +0.03 (0.58%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.13 | 52 Week High | $18.00 | |||
| Open | $5.15 | 52 Week Low | $6.91 | |||
| Day High | $5.17 | P/E | N/A | |||
| Day Low | $5.05 | EPS | $-0.67 | |||
| Volume | 938,827 | |||||
